Aging is the bane of our human existence. It is responsible for degenerative diseases of the body and mind and is the cause of much pain, suffering, and diminished quality of life. It is a constant reminder of our mortality. Assuming that mortality is not a disease, and that aging is an intrinsic property of mortality, aging itself is not a disease. But the degenerative features of many diseases are the by-product of aging. Thus it would seem intuitively desirable to intervene in and decelerate or arrest this process. If this intervention were successful, then it could slow the development of and perhaps even prevent diseases and thereby extend the human lifespan. Decelerated and arrested aging could greatly improve the quality of life and increase the well-being of many people.
In this chapter, I explore medical, social, and psychological dimensions of these two types of intervention aimed at altering aging. Regenerative medicine may be a mixed blessing. In many cases, it could result in a modest increase in the lifespan. But it could also entail a trade-off between increased quantity and quality of life in terms of physical function and decreased quality of life in terms of cognitive function. This could cancel out any early benefits of the intervention. A similar trade-off could occur to a greater degree if genetic manipulation of aging mechanisms substantially extended the lifespan. Whether this would benefit us would depend on whether we could retain equal physical and cognitive functioning through the extended period of our lives. In addition, tinkering with genes to decelerate or arrest aging might unleash growth factors normally suppressed by these same genes and result in diseases such as cancer. Even a modest increase in the lifespan for the elderly could be unfair to the young by burdening them in different ways. At a deeper level, such an increase could alter the natural contour of a human life and its component stages. Much of the discussion in this chapter is speculative, especially with respect to the second type of intervention I have described. Nevertheless, given our understanding of the biology of aging and the theoretical possibility of extending the human lifespan, speculation can be the catalyst for consideration of issues raised by intervention in the aging process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brock D (2002) Priority to the Worst Off in Health Care Resource Prioritization. In: Rhodes R, Battin M, Silvers A (eds) Medicine and Social Justice: Essays on the Distribution of Health Care. Oxford University Press, New York: 362–372
Callahan D (1987) Setting Limits: Medical Goals in an Aging Society. Simon & Schuster, New York
Callahan D (1990) What Kind of Life: The Limits of Medical Progress. Simon & Schuster, New York
Callahan D (1993) The Troubled Dream of Life: Living with Mortality. Simon & Schuster, New York
DeGrazia D (2005) Human Identity and Bioethics. Cambridge University Press, New York
Fries J (1980) Aging, Natural Death and the Compression of Morbidity. New England Journal of Medicine 303: 130–136
Fukuyama F (2002) Our Posthuman Future: Consequences of the Biotechnology Revolution. Farrar, Straus & Giroux, New York
Gems D (2003) Is More Life Always Better? The New Biology of Aging and the Meaning of Life. Hastings Center Report 33 (July–August): 31–39
Greaves M (2007) Darwinian Medicine: A Case for Cancer. Nature Reviews Cancer 7: 213–221
Guarente L, Kenyon C (2000) Genetic Pathways that Regulate Aging in Model Organisms. Nature 408: 255–262
Harris J (2000) Intimations of Immortality. Science 288: 59
Harris J (2007) Enhancing Evolution. The Ethical Case for Making Better People. Princeton University Press, Princeton, NJ.
Hayflick L (1965) The Limited In Vitro Lifetime of Human Diploid Cell Strains. Experimental Cell Research 37: 614–636
Hayflick L (1977) The Cellular Basis for Biological Aging. In: Hayflick L, Finch C (eds) Handbook of the Biology of Aging. Van Nostrand, New York: 159–186
Hayflick L (2001) The Future of Aging. Nature 408: 267–269
Hayflick L (2001–2002) Anti-Aging-Medicine: Hype, Hope, and Reality. Generations: 20–26
Hayflick L, Moorhead P S (1961) The Serial Cultivation of Human Diploid Cell Strains. Experimental Cell Research 25: 585–621
Hekimi S, Guarente L (2003) Genetics and the Specificity of the Aging Process. Science 299: 1351–1354
Hick J (1993) Disputed Questions in Theology and the Philosophy of Religion. Yale University Press, New Haven
Jonsen A, Siegler M, Winslade W (2002) Clinical Ethics. 5th edition, McGraw-Hill, New York
Juengst E T et al. (2003) Biogerontology, ‘Anti-Aging Medicine’ and the Challenges of Human Enhancement. Hastings Center Report 33 (July–August): 21–30
Kass L (2003a) Ageless Bodies, Happy Souls: Biotechnology and the Pursuit of Perfection. The New Atlantis 1: 9–28
Kass L (2003b) Beyond Therapy: Biotechnology and the Pursuit of Happiness. Harper Collins, New York
Kirkland J (2002) The Biology of Senescence: Potential for Prevention of Disease. Clinical Geriatric Medicine 18: 383–405
Kirkwood T (2001) Time of Our Lives: The Science of Human Aging. Oxford University Press, Oxford
Kirkwood T (2008) A Systematic Look at an Old Problem. Nature 451: 644–647.
Lithgow G J, Kirkwood T B (1996) Mechanisms and Evolution of Aging. Science 273: 80
Mahowald M (2003) Reflections on the Human Embryonic Stem Cell Debate. Perspectives in Biology and Medicine 46: 131–141
McHugh P (2004) Zygote and ‘Clonote’—The Ethical Use of Embryonic Stem Cells. New England Journal of Medicine 351: 209–211
McKerlie D (2001) Justice Between the Young and the Old. Philosophy & Public Affairs 30: 152–177
Nesse R, Williams G (1994) Why We Get Sick: The New Science of Darwinian Medicine. Times Books, New York
Olshansky S J, Carnes B A (2001) The Quest for Immortality: Science at the Frontiers of Aging. W. W. Norton, New York
Olshansky S J et al. (2005) A Potential Decline in Life Expectancy in the United States in the 21st Century. New England Journal of Medicine 352: 1138–1145
Parfit D (1984) Reasons and Persons. Clarendon, Oxford
Sandel M (2004) Embryonic Ethics —The Moral Logic of Stem-Cell Research. New England Journal of Medicine 351: 207–209
Schechtman M (1997) The Constitution of Selves. Cornell University Press, Ithaca, NY
Williams B (1973) Problems of the Self. Cambridge University Press, Cambridge
Williams G (1957) Pleiotropy, Natural Selection and the Evolution of Senescence. Evolution 11: 398–411
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science + Business Media B.V
About this chapter
Cite this chapter
Glannon, W. (2008). Decelerating and Arresting Human Aging. In: Gordijn, B., Chadwick, R. (eds) Medical Enhancement and Posthumanity. The International Library of Ethics, Law and Technology, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-8852-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-4020-8852-0_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-8851-3
Online ISBN: 978-1-4020-8852-0
eBook Packages: MedicineMedicine (R0)